Abstract

Disease–modifying drugs for multiple sclerosis and progressive multifocal encephalopathy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A Pilot Study of Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy with Ex Vivo Generated Polyomavirus-Specific T-Cells
Austin John Barrett ... Matthew Schindler
Blood | VOL. 132
Austin John Barrett, et. al.Austin John Barrett ... Matthew Schindler
29 Nov 2018
Progressive Multifocal Encephalopathy in a Patient with Advanced Liver Cirrhosis
Laura Patwa ... Khurram Bari
American Journal of Gastroenterology | VOL. 111
Laura Patwa, et. al.Laura Patwa ... Khurram Bari
01 Oct 2016
Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy
Lee A Tan ... Demetrius K Lopes
Journal of Clinical Neuroscience | VOL. 22
Lee A Tan, et. al.Lee A Tan ... Demetrius K Lopes
24 Jun 2015
Advances in Treatment of Progressive Multifocal Leukoencephalopathy.
Igor J Koralnik ... Renaud Du Pasquier
Annals of neurology | VOL. 90
Igor J Koralnik, et. al.Igor J Koralnik ... Renaud Du Pasquier
07 Sep 2021
View more papers

More From: Neurological Therapeutics

Paper Title
Journal
Date
Author
特集にあたって
...
Neurological Therapeutics | VOL. 39
, et. al. ...
01 Jan 2021
先進PETプローブを用いた生体内イメージング技術で高齢者の神経変性パーキンソニズムの病態にせまる
...
Neurological Therapeutics | VOL. 39
, et. al. ...
01 Jan 2021
Neurovascular unit crosstalk with systemic biology : a paradigm for translational stroke research
Neurological Therapeutics | VOL. 39
01 Jan 2021
Pathophysiological biomarker–based clinical development of lecanemab (BAN2401), anti–Aβ protofibril antibody
Neurological Therapeutics | VOL. 39
01 Jan 2021
View more papers